I didn’t believe the president was being well advised on the drug and research evaluating its use in COVID. A group of outside doctors had gained access to the Oval Office and advanced their anecdotal experiences as proof of its purported efficacy. Some of these meetings were attended by FDA commissioner Stephen Hahn, whose involvement lent further credence to the speculative therapy.30 The drug soon became a political ambition for those who believed it could bring an end to COVID, and it continued to be promoted heavily by a handful of TV commentators. During a single two-week period between
...more
